Breadcrumbs Home News & Events Press Releases Press Releases Year All2026202520242023202220212020201920182017201620152014201320122011201020092008 Type AllRegulatoryNon-regulatory Jul 09, 2020 BioInvent's Board of Directors resolve on a repair rights issue of a maximum of approx. SEK 139 million, following the successfully completed directed share issue of approx. SEK 487 million Jul 08, 2020 BioInvent publishes prospectus regarding admission to trading of newly issued shares on Nasdaq Stockholm Jul 03, 2020 Resolutions at the Extraordinary General Meeting in BioInvent on July 3, 2020 Jul 01, 2020 BioInvent extends research collaboration and license agreement with Pfizer Inc. Jun 30, 2020 BioInvent submits a CTA for a Phase I/IIa trial of BI-1808, a first-in-class anti-TNFR2 antibody for the treatment of patients with solid tumors and CTCL Jun 30, 2020 Change in the number of shares and votes in BioInvent International AB Pagination First page Previous page … Page 36 Current page 37 Page 38 Page 39 … Next page Last page
